{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:24:00Z","timestamp":1787772240343,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:p>Tumour necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) is a member of the TNF superfamily (TNFSF). It acts through its receptor fibroblast growth factor-inducible 14 (Fn14). Studies have indicated that TWEAK\/Fn14 pathway activation controls multiple cellular responses, including proliferation, angiogenesis and induction of inflammatory cytokines. TWEAK\/Fn14 is manifested in many tissues of our body and most importantly in the skin causing inflammation and many autoimmune and neoplastic cutaneous disorders. Evidence suggests that the TWEAK\/Fn14 axis, the downstream signalling pathway and its inflammatory molecular expressions are involved in the pathogenesis of many cutaneous disorders such as psoriasis, atopic dermatitis (AD) vitiligo and melanoma. So, this literature review describes a brief introduction of TWEAK and TWEAK\/Fn14 pathway and summarises the case-series and open-label studies performed in the field of dermatology and its potential therapeutic benefit.<\/jats:p>","DOI":"10.4103\/ijd.ijd_885_22","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T02:26:16Z","timestamp":1715739976000},"page":"425-429","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["TWEAK Progress in Dermatology: A Review"],"prefix":"10.4103","volume":"68","author":[{"given":"Pramisha","family":"Kharel","sequence":"first","affiliation":[{"name":"From the Department of Rheumatology and Immunology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Jia","sequence":"additional","affiliation":[{"name":"From the Department of Rheumatology and Immunology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal Raj","family":"Dhital","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Radiant Health Care, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pukar","family":"Chapagain","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Lucent Skin and Hair Care, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabita","family":"Aryal","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1359-6101(03)00019-4","article-title":"TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR\/Fn14 receptor","volume":"14","author":"Wiley","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrd2488","article-title":"The TWEAK-Fn14 cytokine-receptor axis: Discovery, biology and therapeutic targeting","volume":"7","author":"Winkles","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cyto.2015.10.004","article-title":"Serum levels of TWEAK in patients with psoriasis vulgaris","volume":"77","author":"Bilgi\u00e7","year":"2016","journal-title":"Cytokine"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"155391","DOI":"10.1016\/j.cyto.2020.155391","article-title":"Involvement of the cytokine TWEAK in the pathogenesis of psoriasis vulgaris, pustular psoriasis, and erythrodermic psoriasis","volume":"138","author":"Wang","year":"2021","journal-title":"Cytokine"},{"issue":"Suppl 1","key":"R7-20240829","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic dermatitis: Global epidemiology and risk factors","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jaad.2020.08.004","article-title":"Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in psoriasis and atopic dermatitis: A case control study","volume":"84","author":"Nada","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/cei.13373","article-title":"Experimental atopic dermatitis is dependent on the TWEAK\/Fn14 signaling pathway","volume":"199","author":"Liu","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/jocd.13644","article-title":"Serum TWEAK: A cutoff between segmental and nonsegmental vitiligo","volume":"20","author":"El-Taweel","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams","year":"2012","journal-title":"Lancet"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/jocd.13011","article-title":"Serum TWEAK in acne vulgaris: An unknown soldier","volume":"19","author":"El-Taweel","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.berh.2013.07.008","article-title":"Cutaneous lupus erythematosus: Diagnosis and treatment","volume":"27","author":"Okon","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/jid.2015.124","article-title":"TWEAK\/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL\/lpr Model of Spontaneous Lupus","volume":"135","author":"Doerner","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0140-6736(07)60474-7","article-title":"Clinical update: Henoch-Sch\u00f6nlein purpura","volume":"369","author":"Saulsbury","year":"2007","journal-title":"Lancet"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2249.2011.04442.x","article-title":"Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura","volume":"166","author":"Chen","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: Overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R19-20240829","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jid.2017.03.019","article-title":"TWEAK\/Fn14 activation contributes to the pathogenesis of bullous pemphigoid","volume":"137","author":"Liu","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(92)70069-R","article-title":"Urticarial vasculitis: A histopathologic and clinical review of 72 cases","volume":"26","author":"Mehregan","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"R21-20240829","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/1346-8138.12251","article-title":"Tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 are expressed in urticarial vasculitis","volume":"40","author":"Li","year":"2013","journal-title":"J Dermatol"},{"key":"R22-20240829","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"R23-20240829","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3899\/jrheum.081310","article-title":"Elevated circulating TWEAK levels in systemic sclerosis: Association with lower frequency of pulmonary fibrosis","volume":"36","author":"Yanaba","year":"2009","journal-title":"J Rheumatol"},{"key":"R24-20240829","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N Engl J Med"},{"key":"R25-20240829","doi-asserted-by":"crossref","first-page":"81474","DOI":"10.18632\/oncotarget.13034","article-title":"TWEAK activation of the non-canonical NF-\u03baB signaling pathway differentially regulates melanoma and prostate cancer cell invasion","volume":"7","author":"Armstrong","year":"2016","journal-title":"Oncotarget"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_885_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:33:47Z","timestamp":1787769227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_885_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_885_22","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2022-11-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}